Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.

[1]  M. Mack,et al.  The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[2]  Samin K. Sharma,et al.  The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease. , 2017, JACC. Cardiovascular interventions.

[3]  P. Pellikka,et al.  Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review. , 2017, Kidney international.

[4]  V. Fuster,et al.  Coronary artery disease Comparative efficacy of coronary artery bypass surgery vs . percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease , 2016 .

[5]  S. Bangalore,et al.  Optimal Treatment Strategies in Patients with Chronic Kidney Disease and Coronary Artery Disease. , 2016, The American journal of medicine.

[6]  Yinfeng Jiang,et al.  Comparison of Drug‐Eluting and Bare Metal Stents in Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta‐Analysis , 2016, Journal of the American Heart Association.

[7]  S. Pocock,et al.  Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. , 2016, The New England journal of medicine.

[8]  K. Park,et al.  Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry. , 2016, JACC. Cardiovascular interventions.

[9]  S. Bangalore.  Diagnostic, Therapeutic, and Clinical Trial Conundrum of Patients With Chronic Kidney Disease. , 2016, JACC. Cardiovascular interventions.

[10]  B. Gersh,et al.  Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[11]  P. Serruys,et al.  Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease. , 2016, Journal of the American College of Cardiology.

[12]  S. Pocock,et al.  Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. , 2016, JACC. Cardiovascular interventions.

[13]  S. Pocock,et al.  Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. , 2016, Journal of the American College of Cardiology.

[14]  P. Serruys,et al.  Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis. , 2016, JACC. Cardiovascular interventions.

[15]  P. Teirstein,et al.  One‐year results of the ICON (ionic versus non‐ionic contrast to obviate worsening nephropathy after angioplasty in chronic renal failure patients) Study , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[16]  P. Serruys,et al.  Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials. , 2016, JACC. Cardiovascular interventions.

[17]  B. Gersh,et al.  Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention , 2016, American heart journal.

[18]  Peter L Duffy,et al.  Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. , 2015, Journal of the American College of Cardiology.

[19]  E. Hannan,et al.  Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery. , 2015, Journal of the American College of Cardiology.

[20]  S. Windecker,et al.  Stable coronary artery disease: revascularisation and invasive strategies , 2015, The Lancet.

[21]  G. Stone,et al.  Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials , 2015, Circulation. Cardiovascular interventions.

[22]  R. Mehran,et al.  Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug-Dosing Recommendations and Risk Stratification in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions. , 2015, Journal of the American College of Cardiology.

[23]  R. Mehran,et al.  PCI and CABG surgery in 2014: CABG surgery versus PCI in CAD—surgery strikes again! , 2015, Nature Reviews Cardiology.

[24]  A. Levin,et al.  Practice Guideline , 2020, Encyclopedia of Behavioral Medicine.

[25]  Norbert Lameire,et al.  Notice , 2012, Kidney International Supplements.

[26]  S. Pocock,et al.  A risk score to predict bleeding in patients with acute coronary syndromes. , 2010, Journal of the American College of Cardiology.

[27]  L. Stevens,et al.  Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[29]  G. Filardo,et al.  New-Onset Postoperative Atrial Fibrillation After Isolated Coronary Artery Bypass Graft Surgery and Long-Term Survival , 2009, Circulation. Cardiovascular quality and outcomes.

[30]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[31]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[32]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.